Nat Rev Drug Discov. 2007 Jan;6(1):29-40. Epub 2006 Dec 8.

Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL.

Source

Infectious Diseases Centre of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, USA.

Abstract

The sequencing of the first complete bacterial genome in 1995 heralded a new era of hope for antibacterial drug discoverers, who now had the tools to search entire genomes for new antibacterial targets. Several companies, including GlaxoSmithKline, moved back into the antibacterials area and embraced a genomics-derived, target-based approach to screen for new classes of drugs with novel modes of action. Here, we share our experience of evaluating more than 300 genes and 70 high-throughput screening campaigns over a period of 7 years, and look at what we learned and how that has influenced GlaxoSmithKline's antibacterials strategy going forward.

PMID:: 17159923; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Anti-Bacterial Agents

LinkOut - more resources

Full Text Sources

Other Literature Sources

Evaluations and comments from leading biologists - Faculty of 1000 Biology

Medical

Supplemental Content

Related citations

Review When will the genomics investment pay off for antibacterial discovery? [Biochem Pharmacol. 2006]
Review When will the genomics investment pay off for antibacterial discovery?
Mills SD. Biochem Pharmacol. 2006 Mar 30; 71(7):1096-102. Epub 2006 Jan 4.
Review Antibacterial drug discovery in the post-genomics era. [Curr Drug Targets Infect Disord. 2002]
Review Antibacterial drug discovery in the post-genomics era.
Lerner CG, Beutel BA. Curr Drug Targets Infect Disord. 2002 Jun; 2(2):109-19.
Review [Development of antituberculous drugs: current status and future prospects]. [Kekkaku. 2006]
Review [Development of antituberculous drugs: current status and future prospects].
Tomioka H, Namba K. Kekkaku. 2006 Dec; 81(12):753-74.
Review Functional genomics in antibacterial drug discovery. [Drug Discov Today. 2005]
Review Functional genomics in antibacterial drug discovery.
Freiberg C, Brötz-Oesterhelt H. Drug Discov Today. 2005 Jul 1; 10(13):927-35.
Review The millennium bugs--the need for and development of new antibacterials. [Int J Antimicrob Agents. 2000]
Review The millennium bugs--the need for and development of new antibacterials.
Bax R, Mullan N, Verhoef J. Int J Antimicrob Agents. 2000 Sep; 16(1):51-9.

See reviews... See all...

Cited by 89 PubMed Central articles

A riboswitch-based inducible gene expression system for mycobacteria. [PLoS One. 2012]
A riboswitch-based inducible gene expression system for mycobacteria.
Seeliger JC, Topp S, Sogi KM, Previti ML, Gallivan JP, Bertozzi CR. PLoS One. 2012; 7(1):e29266. Epub 2012 Jan 18.
Discovery of novel MDR-Mycobacterium tuberculosis inhibitor by new FRIGATE computational screen. [PLoS One. 2011]
Discovery of novel MDR-Mycobacterium tuberculosis inhibitor by new FRIGATE computational screen.
Scheich C, Szabadka Z, Vértessy B, Pütter V, Grolmusz V, Schade M. PLoS One. 2011; 6(12):e28428. Epub 2011 Dec 2.
Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expression. [PLoS Pathog. 2011]
Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expression.
Woong Park S, Klotzsche M, Wilson DJ, Boshoff HI, Eoh H, Manjunatha U, Blumenthal A, Rhee K, Barry CE 3rd, Aldrich CC, et al. PLoS Pathog. 2011 Sep; 7(9):e1002264. Epub 2011 Sep 29.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Drugs for bad bugs: confronting the challenges of antibacterial discovery.
Drugs for bad bugs: confronting the challenges of antibacterial discovery.
Nat Rev Drug Discov. 2007 Jan ;6(1):29-40. Epub 2006 Dec 8 .

PubMed
Interaction of Arl1-GTP with GRIP domains recruits autoantigens Golgin-97 and Go...
Interaction of Arl1-GTP with GRIP domains recruits autoantigens Golgin-97 and Golgin-245/p230 onto the Golgi.
Mol Biol Cell. 2003 Sep ;14(9):3767-81. Epub 2003 May 18 .

PubMed
Pathway-based approaches for analysis of genomewide association studies.
Pathway-based approaches for analysis of genomewide association studies.
Am J Hum Genet. 2007 Dec ;81(6):1278-83.

PubMed
Time to give up on a single explanation for autism.
Time to give up on a single explanation for autism.
Nat Neurosci. 2006 Oct ;9(10):1218-20.

PubMed
The effect of graded postischemic spinal cord hypothermia on neurological outcom...
The effect of graded postischemic spinal cord hypothermia on neurological outcome and histopathology after transient spinal ischemia in rat.
Anesthesiology. 1999 Mar ;90(3):789-98.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: